Education
About Us
Working with TipRanks
Follow Us
Vera Therapeutics, Inc. (VERA)
NASDAQ:VERA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 846.00K | $ 0.00 |
| Operating Income | $ -315.47M | $ -167.17M | $ -102.01M | $ -90.90M | $ -34.40M |
| EBITDA | $ -299.15M | $ -144.42M | $ -92.18M | $ -88.91M | $ -32.41M |
| Net Income | $ -299.62M | $ -152.15M | $ -95.99M | $ -89.06M | $ -32.61M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 714.59M | $ 640.85M | $ 160.72M | $ 114.65M | $ 79.67M |
| Total Assets | $ 734.73M | $ 655.68M | $ 175.55M | $ 131.44M | $ 83.75M |
| Total Debt | $ 77.31M | $ 54.64M | $ 53.71M | $ 31.29M | $ 4.92M |
| Net Debt | $ -277.42M | $ -38.01M | $ 8.03M | $ -12.17M | $ -74.75M |
| Total Liabilities | $ 130.21M | $ 78.53M | $ 73.86M | $ 54.53M | $ 14.16M |
| Stockholders' Equity | $ 604.52M | $ 577.15M | $ 101.69M | $ 76.91M | $ 69.59M |
| Cash Flow | |||||
| Free Cash Flow | $ -241.73M | $ -135.65M | $ -92.24M | $ -67.66M | $ -23.71M |
| Operating Cash Flow | $ -241.10M | $ -134.68M | $ -92.18M | $ -67.60M | $ -23.71M |
| Investing Cash Flow | $ 194.29M | $ -425.03M | $ -39.43M | $ -70.55M | $ -4.20M |
| Financing Cash Flow | $ 308.90M | $ 606.67M | $ 133.54M | $ 101.93M | $ 53.88M |